Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

Clinical trial NCT01347996 · COMPLETED

Trial details

NCT number: NCT01347996
Sponsor: Cytovia, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2009-07-01
Primary completion: 2014-06-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.